Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOberon Investments Group Plc Regulatory News (OBE.PL)

Share Price Information for Oberon Investments Group Plc (OBE.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.05    0.00 (0.00%)
Bid:
2.00
Ask:
2.10
Spread: 0.10 (5.00%)
Market Cap: £16.40m
OBE.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Oberon Investments Group Plc Share Chart

Directorate Changes

17 Oct 2024 07:00

RNS Number : 5002I
Oberon Investments Group PLC
17 October 2024
 

17 October 2024

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. Which is part of the United Kingdom domestic law pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310) ("UK MAR").

 

Oberon Investments Group plc("Oberon" or the "Company")

Directorate changes

Oberon Investments Group plc (AQSE: OBE), the boutique investment management, wealth planning and corporate broking group, announces the promotion of Adam Herringer as Group Chief Operating Officer and his appointment as board member, with immediate effect. Adam joined Oberon in November 2021 as COO of Capital and Head of Change, since joining Adam has worked closely with the CEO Simon McGivern and has been integral in driving group initiatives and supporting the growth of Oberon.

Simon McGivern, CEO Oberon of Investments Group plc, said:

"I am pleased to announce the promotion of Adam Herringer to Group Chief Operating Officer. Since joining Oberon, Adam has been instrumental in supporting the execution of our growth strategy. His promotion reflects his contributions and the trust we place in his ability to lead our operations as we continue to scale and innovate. I look forward to continuing our work together."

Adam Herringer, commented:

"I am grateful for the trust and support I have received from the team at Oberon. It is a privilege to be part of such a talented group of people who are dedicated to growing and evolving our business. I am excited about the future as we work together to achieve our strategic goals and deliver value to our clients and stakeholders"

Adam Herringer

 

The directors of Oberon accept responsibility for this announcement.

 

Enquiries

Oberon Investments Group plc Simon McGivern / John Beaumont

 

020 3179 5300

Novum Securities Limited (AQSE Corporate Adviser and Broker to the Company) Richard Potts / George Duxberry

 

020 7399 9400

Oberon Capital (Broker to the Company)

Mike Seabrook / Nick Lovering

020 3179 5300

 

 

 

 

Disclosures required pursuant to Rule 4.9 of the Aquis Apex Rules for Companies

Under the EMI scheme, Adam Herringer has the right to 1,222,654 options over ordinary shares in the Company.

The names of all companies and partnerships of which Adam Herringer has been a director or partner at any time in the previous five years are set out below:

Current directorships or partnerships

Previous directorships or partnerships

Logic Investments Limited

Herringer Labs Ltd

 

 

 

Except as set out above, there is no further information regarding Adam Herringer that is required to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXKZMMGVVFGDZM
12
Date   Source Headline
17th Sep 20247:00 amRNSSenior investment teams join Oberon
6th Sep 20244:45 pmRNSHolding(s) in Company
5th Sep 20247:00 amRNSHolding(s) in Company
3rd Sep 20241:43 pmRNSResult of AGM
30th Aug 20247:00 amRNSTotal Voting Rights
12th Aug 202411:54 amRNSHolding(s) in Company
12th Aug 202411:48 amRNSHolding(s) in Company
6th Aug 20247:00 amRNSConditional Placing, Trading Update & AGM Notice
26th Jul 20247:00 amRNSResults for the year ended 31 March 2024
28th Jun 20247:00 amRNSIssue of Options
13th Jun 20247:00 amRNSTrading Update for the year ended 31 March 2024
3rd Jun 20243:54 pmRNSDirectorate Change
23rd Apr 20241:57 pmRNSHolding(s) in Company
5th Apr 202411:10 amRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSAppointment of Nicola Mitford-Slade
29th Dec 20237:00 amRNSTotal Voting Rights
28th Dec 20235:32 pmRNSCorrection: Half-year Report
28th Dec 20237:00 amRNSHalf-year Report
18th Dec 20237:05 amRNSHolding(s) in Company
18th Dec 20237:00 amRNSAcquisition of Nexus Investments Evergreen EIS
11th Dec 20237:00 amRNSSenior Investment Manager joins Oberon Investments
13th Nov 20237:00 amRNSMove to Apex Segment of the AQSE Growth Market
26th Oct 202310:46 amBUSHolding(s) in Company
23rd Oct 202312:19 pmRNSDirectorate Change
20th Oct 20235:48 pmRNSHolding(s) in Company
20th Oct 20235:43 pmRNSDirector share dealing
4th Oct 20233:09 pmRNSHolding(s) in Company
29th Sep 202311:31 amRNSHolding(s) in Company
28th Sep 20234:49 pmRNSHolding(s) in Company
28th Sep 20234:41 pmRNSHolding(s) in Company
28th Sep 20234:26 pmRNSHolding(s) in Company
28th Sep 20234:21 pmRNSHolding(s) in Company
26th Sep 20237:00 amRNSResult of Retail Offer and Placing
21st Sep 20233:20 pmRNSResult of AGM
19th Sep 20237:10 amRNSWRAP Retail Offer for up to £500,000
19th Sep 20237:00 amRNSConditional placing to raise £2.5 million
21st Aug 20237:00 amRNSNotice of AGM
15th Aug 20237:00 amRNSTR-1: Notification of major holdings
7th Aug 20237:00 amRNSDirector Dealing
28th Jul 20237:00 amRNSResults for the year ended 31 March 2023
20th Jul 20237:00 amRNSAcquisition of Nexus Investments Evergreen EIS
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.